Department of Dermatology Clinical Trials

Hand Eczema Study - Pittsburgh Doctors at UPMC in Pittsburgh are conducting a new study to treat hand eczema. No cost to join. Compensation provided.

Seborrheic Dermatitis Study at UPMC Doctors at UPMC in Pittsburgh are offering a new clinical study to help treat seborrheic dermatitis. No cost to join. Learn more.

Psoriasis Study in Pittsburgh Doctors at UPMC are conducting a new study to help people with psoriasis. No cost to participate. Learn more.

https://www.upmc.com/media/news/040220-falo-gambotto-sars-cov2-vaccine

COVID-19 Vaccine Candidate Shows Promise A potential COVID-19 vaccine, delivered by microscopic needles, produces antibodies in mice. The next step is a human clinical trial.

Have you been told you have a rare skin disease called Palmoplantar Pustulosis, also referred to as PPP? If so, you may be eligible for a clinical research study being conducted locally that evaluates an investigational drug for this disease.

You may be able to participate in this research study if you:

• Are between the ages of 18-75 years old
• Have been diagnosed with PPP
• Have white or yellow blisters filled with pus on the palms of your hands and/or soles of your feet, surrounded by red patches of skin
• Meet additional study criteria
For eligible participants, all study-related visits, procedures, and investigational drugs will be provided at no cost to you.

To see if you qualify, contact:
Laura Ferris, MD, PhD
UPMC Department of Dermatology Clinical Trials
[email protected]

Do you have eczema? You may qualify for a clinical trial researching a new treatment option.

https://pittplusme.org/studyarms/publicdetails?guid=c214b56c-96dc-472e-8c6e-d8a9c9016af5

Pitt+Me - A Study to Assess Nemolizumab in Participants with Moderate to Severe Atopic Dermatitis (Eczema) Have you had atopic dermatitis (eczema) for at least 2 years? If so, you may be able to participate in a study to help determine how safe and effective a study drug, called nemolizumab, is in treating atopic dermatitis. Study participation may last up to 60 weeks and may involve up to 16 study visit...

Are you interested in helping us get more information about psoriasis?

https://pittplusme.org/studyarms/publicdetails?guid=a0695f61-2a1f-460f-91ec-3695a680c6b2

Pitt+Me - Psoriasis Skin Sample Study Have you been diagnosed by a physician with moderate to severe psoriasis? If so, you may be eligible to participate in a research study to help learn more about the role of genetics, proteins, and the immune system in the development of psoriasis. Compensation provided.

This study may interest you!
https://pittplusme.org/studyarms/publicdetails?guid=ba059851-4173-44cf-b100-460ff77601f6

Pitt+Me - A Study to Evaluate Risankizumab in Participants with Moderate to Severe Atopic Dermatitis Have you been diagnosed with moderate-to-severe atopic dermatitis (eczema) for at least the past 2 years? If so, you may be eligible to participate in a study of an investigational drug called risankizumab in subjects with atopic dermatitis. Involves 11 visits over up to 65 weeks. Compensation is pr...

https://pittplusme.org/studyarms/publicdetails?guid=3a887431-bbed-4d92-8d7e-3f07b7869103

Pitt+Me - Palmoplantar Pustulosis (PPP) Study

Looking for a dermatologist?

University of Pittsburgh, Department of Dermatology With six area locations, The Department of Dermatology incorporates a broad range of clinical services, research, and teaching activities. Clinically, the department offers services in the areas of general dermatology, medical dermatology, pediatric dermatology, dermatologic surgery, dermatopathology, photodermatology, occupational dermatology, cutaneous oncology and cosmetic and aesthetic dermatology.

Check out this study!

https://pittplusme.org/studyarms/publicdetails?guid=c214b56c-96dc-472e-8c6e-d8a9c9016af5

Pitt+Me - A Study to Assess Nemolizumab in Participants with Moderate to Severe Atopic Dermatitis (Eczema) Have you had atopic dermatitis (eczema) for at least 2 years? If so, you may be able to participate in a study to help determine how safe and effective a study drug, called nemolizumab, is in treating atopic dermatitis. Study participation may last up to 60 weeks and may involve up to 16 study visit...

Department of Dermatology Clinical Trials updated their business hours.

Department of Dermatology Clinical Trials updated their website address.

It's now easier to send Department of Dermatology Clinical Trials a message.

Message us for more info!